{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T06:34:59Z","timestamp":1756190099837,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11255-021-02992-7","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T10:29:38Z","timestamp":1632220178000},"page":"1261-1269","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hypocitraturia is present when renal function is impaired in diverse nephropathies and is not related with serum bicarbonate levels"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8861-3132","authenticated-orcid":false,"given":"Francisco Jos\u00e9","family":"Borrego Utiel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidoro","family":"Herrera Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enoc","family":"Merino Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Moriana Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Oca\u00f1a P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jos\u00e9","family":"Garc\u00eda Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,21]]},"reference":[{"key":"2992_CR1","doi-asserted-by":"publisher","first-page":"838","DOI":"10.2215\/CJN.03100608","volume":"4","author":"JL Nishiura","year":"2009","unstructured":"Nishiura JL, Neves RFCA, Eloi SRM, Cintra SMLF, Ajzen SA, Heilberg IP (2009) Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol 4:838\u2013844","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"2992_CR2","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0272-6386(12)80922-X","volume":"22","author":"VE Torres","year":"1993","unstructured":"Torres VE, Wilson DM, Hattery RR, Segura JW (1993) Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis 22(4):513\u2013519","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"2992_CR3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0272-6386(88)80137-9","volume":"11","author":"VE Torres","year":"1988","unstructured":"Torres VE, Erickson SB, Smith LH, Wilson DM, Hattery RR, Segura JW (1988) The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis 11(4):318\u2013325","journal-title":"Am J Kidney Dis"},{"key":"2992_CR4","first-page":"F63","volume":"272","author":"MR Ogborn","year":"1997","unstructured":"Ogborn MR, Sareen S, Prychitko J, Buist R, Peeling J (1997) Altered organic anion and osmolyte content and excretion in rat polycystic kidney disease: an NMR study. Am J Physiol 272:F63\u2013F69","journal-title":"Am J Physiol"},{"key":"2992_CR5","doi-asserted-by":"publisher","unstructured":"Borrego Utiel FJ, Herrera Contreras I, Merino Garc\u00eda E, Camacho Reina MV, Moriana Dom\u00ednguez C, Oca\u00f1a P\u00e9rez E (2021) Urinary citrate as a marker of renal function in patients with autosomal dominant polycystic kidney disease. Int Urol Nephrol. https:\/\/doi.org\/10.1007\/s11255-021-02953-0","DOI":"10.1007\/s11255-021-02953-0"},{"key":"2992_CR6","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/ki.1990.265","volume":"38","author":"LL Hamm","year":"1990","unstructured":"Hamm LL (1990) Renal handling of citrate. Kidney Int 38:728\u2013735","journal-title":"Kidney Int"},{"key":"2992_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0025-7125(16)32009-0","volume":"59","author":"SB Baruch","year":"1975","unstructured":"Baruch SB, Burich RL, Eun CK, King VF (1975) Renal metabolism of citrate. Med Clin N Am 59:569\u2013582","journal-title":"Med Clin N Am"},{"key":"2992_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000080259","volume":"98","author":"RJ Unwin","year":"2004","unstructured":"Unwin RJ, Capasso G, Shirley DG (2004) An overview of divalent cation and citrate handling by the kidney. Nephrol Physiol 98:15\u201320","journal-title":"Nephrol Physiol"},{"issue":"3","key":"2992_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00240-014-0653-4","volume":"42","author":"KS Hering-Smith","year":"2014","unstructured":"Hering-Smith KS, Mao W, Schiro FR, Coleman-Barnett J, Pajor AM, Hamm LL (2014) Localization of the calcium regulated citrate transport process in proximal tubule cells. Urolithiasis 42(3):209\u20132019","journal-title":"Urolithiasis"},{"issue":"6","key":"2992_CR10","doi-asserted-by":"publisher","first-page":"901","DOI":"10.2215\/CJN.07190712","volume":"8","author":"EI Mandel","year":"2013","unstructured":"Mandel EI, Taylor EN, Curhan GC (2013) Dietary and lifestyle factors and medical conditions associated with urinary citrate excretion. Clin J Am Soc Nephrol 8(6):901\u2013908","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"2992_CR11","first-page":"134","volume":"11","author":"JM Zuckerman","year":"2009","unstructured":"Zuckerman JM, Assimos DG (2009) Hypocitraturia: pathophysiology and medical management. Rev Urol 11(3):134\u2013144","journal-title":"Rev Urol"},{"issue":"5","key":"2992_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177329","volume":"12","author":"V Forni Ogna","year":"2017","unstructured":"Forni Ogna V, Blanchard A, Vargas-Poussou R, Ogna A, Baron S, Bertocchio JP et al (2017) Signification of distal urinary acidification defects in hypocitraturic patients. PLoS ONE 12(5):e0177329. https:\/\/doi.org\/10.1371\/journal.pone.0177329","journal-title":"PLoS ONE"},{"issue":"2","key":"2992_CR13","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1210\/jcem-72-2-396","volume":"72","author":"K Sakhaee","year":"1991","unstructured":"Sakhaee K, Alpern R, Jacobson HR, Pak CY (1991) Contrasting effects of various potassium salts on renal citrate excretion. J Clin Endocrinol Metab 72(2):396\u2013400","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2992_CR14","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.eururo.2014.10.029","volume":"67","author":"A Skolarikos","year":"2015","unstructured":"Skolarikos A, Straub M, Knoll Th, Sarica K, Seitz Ch, Petrik A, Turk Ch (2015) Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur Urol 67(4):750\u2013763","journal-title":"Eur Urol"},{"issue":"5","key":"2992_CR15","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.kint.2018.11.033","volume":"95","author":"N Goraya","year":"2019","unstructured":"Goraya N, Simoni J, Sager LN, Madias NE, Wesson DE (2019) Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis. Kidney Int 95(5):1190\u20131196","journal-title":"Kidney Int"},{"issue":"4","key":"2992_CR16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1159\/000186347","volume":"57","author":"M Marangella","year":"1991","unstructured":"Marangella M, Vitale C, Manganaro M, Cosseddu D, Martini C, Petrarulo M, Linari F (1991) Renal handling of citrate in chronic renal insufficiency. Nephron 57(4):439\u2013443","journal-title":"Nephron"},{"issue":"3","key":"2992_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0003-2697(66)90172-2","volume":"17","author":"H Moellering","year":"1966","unstructured":"Moellering H, Gruber W (1966) Determination of citrate with citrate lyase. Anal Biochem 17(3):369\u2013376","journal-title":"Anal Biochem"},{"issue":"2","key":"2992_CR18","first-page":"243","volume":"34","author":"CA Martinez","year":"2014","unstructured":"Martinez CA, G\u00f3rriz JL, Bover J, de la Segura MJ, Cebollada J, Escalada J, Esmatjes E, F\u00e1cila L et al (2014) Documento de consenso para la detecci\u00f3n y manejo de la enfermedad renal cr\u00f3nica. Nefrologia 34(2):243\u2013262","journal-title":"Nefrologia"},{"key":"2992_CR19","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1038\/ki.1994.227","volume":"45","author":"VE Torres","year":"1994","unstructured":"Torres VE, Keith DS, Offord KP, Kon SP, Wilson DM (1994) Renal ammonia in autosomal dominant polycystic kidney disease. Kidney Int 45:1745\u20131753","journal-title":"Kidney Int"},{"issue":"9","key":"2992_CR20","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2215\/CJN.00220110","volume":"5","author":"A Fabris","year":"2010","unstructured":"Fabris A, Lupo A, Bernich P, Abaterusso C, Marchionna N, Nouvenne A, Gambaro G (2010) Long-term treatment with potassium citrate and renal stones in medullary sponge kidney. Clin J Am Soc Nephrol 5(9):1663\u20131668","journal-title":"Clin J Am Soc Nephrol"},{"key":"2992_CR21","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00044.2019","author":"N Goraya","year":"2019","unstructured":"Goraya N, Simoni J, Sager LN, Mamun A, Madias NE, Wesson DE (2019) Urine citrate excretion identifies changes in acid retention as eGFR declines in patients with chronic kidney disease. Am J Renal Physiol. https:\/\/doi.org\/10.1152\/ajprenal.00044.2019","journal-title":"Am J Renal Physiol"},{"key":"2992_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1471-2369-15-63","volume":"15","author":"M Han","year":"2014","unstructured":"Han M, Park HC, Kim H, Jo HA, Huh H, Jang JY et al (2014) Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease. BMC Nephrol 15:63. https:\/\/doi.org\/10.1186\/1471-2369-15-63","journal-title":"BMC Nephrol"},{"key":"2992_CR23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/ndt\/gfs417","volume":"28","author":"I Helal","year":"2013","unstructured":"Helal I, McFann K, Reed B, Yan X, Schrier RW, Fick-Brosnahan GM (2013) Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease. Nephrol Dial Transpl 28:380\u2013385","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"2992_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.rce.2015.09.007","volume":"216","author":"MJ Torres-S\u00e1nchez","year":"2016","unstructured":"Torres-S\u00e1nchez MJ, \u00c1vila-Barranco E, de la Esteban RRJ, Fern\u00e1ndez-Castillo R, Esteban MA, Carrero JJ, Garc\u00eda-Valverde M, Bravo-Soto JA, en representaci\u00f3n del Grupo para el Estudio de la Enfermedad Poliqu\u00edstica Autos\u00f3mica Dominante (GEEPAD) (2016) Relaci\u00f3n entre funci\u00f3n y volumen renal en lapoliquistosis renal autos\u00f3mica dominante: estudio transversal. Rev Clin Esp 216(2):62\u201367","journal-title":"Rev Clin Esp"},{"issue":"1","key":"2992_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0002-9343(90)90097-W","volume":"89","author":"WD Kaehny","year":"1990","unstructured":"Kaehny WD, Tangel DJ, Johnson AM, Kimberling WJ, Schrier RW, Gabow PA (1990) Uric acid handling in autosomal dominant polycystic kidney disease with normal filtration rates. Am J Med 89(1):49\u201352","journal-title":"Am J Med"},{"issue":"10","key":"2992_CR26","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.2215\/CJN.01010211","volume":"6","author":"I Helal","year":"2011","unstructured":"Helal I, Reed B, McFann K, Yan XD, Fick-Brosnahan GM, Cadnapaphornchai M, Schrier RW (2011) Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 6(10):2439\u20132443","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"2992_CR27","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.ackd.2012.05.004","volume":"19","author":"K Nashar","year":"2012","unstructured":"Nashar K, Fried LF (2012) Hyperuricemia and the progression of chronic kidney disease: is uric acid a marker or an independent risk factor? Adv Chronic Kidney Dis 19(6):386\u2013391","journal-title":"Adv Chronic Kidney Dis"},{"key":"2992_CR28","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/ndt\/gft378","volume":"29","author":"B Bose","year":"2014","unstructured":"Bose B, Badve SV, Hiremath SS, Boudville N, Brown FG, Cass A et al (2014) Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis. Nephrol Dial Transpl 29:406\u2013441","journal-title":"Nephrol Dial Transpl"},{"issue":"9","key":"2992_CR29","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1093\/ndt\/gft029","volume":"28","author":"RJ Johnson","year":"2013","unstructured":"Johnson RJ, Nakagawa T, Jalal D, Sanchez-Lozada LG, Kang DH, Ritz E (2013) Uric acid and chronic kidney disease: which is chasing which? Nephrol Dial Transpl 28(9):2221\u20132228","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"2992_CR30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000443415","volume":"41","author":"Y Caliskan","year":"2016","unstructured":"Caliskan Y, Ozluk Y, Celik D, Oztop N, Aksoy A, Ucar AS, Yazici H, Kilicaslan I, Sever MS (2016) The clinical significance of uric acid and complement activation in the progression of IgA nephropathy. Kidney Blood Press Res 41(2):148\u2013157","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"2992_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/ndt\/gfh584","volume":"20","author":"J Myllym\u00e4ki","year":"2005","unstructured":"Myllym\u00e4ki J, Honkanen T, Syrj\u00e4nen J, Helin H, Rantala I, Pasternack A, Mustonen J (2005) Uric acid correlates with the severity of histopathological parameters in IgA nephropathy. Nephrol Dial Transpl 20(1):89\u201395","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"2992_CR32","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1159\/000491809","volume":"43","author":"Y Ruan","year":"2018","unstructured":"Ruan Y, Hong F, Wu J, Lin M, Wang C, Lian F, Cao F, Yang G, Gao M (2018) Clinicopathological characteristics, role of immunosuppressive therapy and progression in IgA nephropathy with hyperuricemia. Kidney Blood Press Res 43(4):1131\u20131140","journal-title":"Kidney Blood Press Res"},{"issue":"4","key":"2992_CR33","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s40620-014-0154-0","volume":"28","author":"T Moriyama","year":"2015","unstructured":"Moriyama T, Itabashi M, Takei T, Kataoka H, Sato M, Shimizu A, Iwabuchi Y, Nishida M, Uchida K, Nitta K (2015) High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a. J Nephrol 28(4):451\u2013456","journal-title":"J Nephrol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-021-02992-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-021-02992-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-021-02992-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T10:16:52Z","timestamp":1652091412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-021-02992-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,21]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["2992"],"URL":"https:\/\/doi.org\/10.1007\/s11255-021-02992-7","relation":{},"ISSN":["1573-2584"],"issn-type":[{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2021,9,21]]},"assertion":[{"value":"12 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors have no conflict of interest to declare. We have not received any financial support for this research. We declare that the results presented in this paper have not been published previously in whole or part, except in abstract format.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}